Contract Award Notice - Provision of end-to-end digital histopathology pathway service with integrated AI diagnostic support and NHS reporting services

Contract Award Notice - Provider Selection Regime (PSR) Provision of End-to-End Digital Histopathology Pathway Service with Integrated AI Diagnostic Support and NHS Reporting Services. This is a Provider Selection Regime (PSR) Contract Award Notice detailing the award of a contract to Inify Laboratories Ltd. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. This Contract Award Notice is published in accordance with Regulation 12 of the Health Care Services (Provider Selection Regime) Regulations 2023. The Most Suitable Provider Process was used to commission this service and award the contract. The related Notice of Intention to Award was previously published under reference 2026/S 000-017292. [017292-2026 | PDF] In accordance with Schedule 7 of the Regulations, the following information is provided: 1. Award of Contract A contract has been awarded to Inify Laboratories Ltd for the provision of an end-to-end digital histopathology pathway service with integrated AI diagnostic support and NHS reporting services. The contract was awarded following completion of the Most Suitable Provider Process. 2. Contract Title and Reference Contract Title: Provision of End-to-End Digital Histopathology Pathway Service with Integrated AI Diagnostic Support and NHS Reporting Services Reference: C407455 3. Awarded Provider Inify Laboratories Ltd 191C Nebula Park Drive Milton Park Oxfordshire OX14 4SE England 4. Description of Services Inify delivers a fully integrated, co-designed diagnostic service that aligns with NHS pathways, enables seamless information sharing and strengthens multidisciplinary collaboration. Its resilient, scalable and digitally enabled model supports long-term service continuity and robust governance. CPV Code: 85111800 - Pathology Services 5. Lifetime Value of the Contract £275,000 6. Contract Term The contract period is: 08 June 2026 to 07 June 2027 The parties may agree to extend the contract for a further period of up to 12 months. 7. Award Decision-Makers The award decision was made by: Cellular & Anatomical Pathology Operations Manager Consultant Histopathologists Category Manager 8. Conflicts of Interest No conflicts of interest or potential conflicts of interest were declared. 9. Management of Conflicts of Interest All decision-makers completed and signed conflict of interest declarations prior to commencement of the provider selection process. No conflicts of interest were identified.